Bill

Bill > HR4955


US HR4955

US HR4955
Protecting Access to Safe and Effective Medicines Act of 2019


summary

Introduced
10/31/2019
In Committee
11/01/2019
Crossed Over
Passed
Dead
12/31/2020

Introduced Session

116th Congress

Bill Summary

A BILL To amend the Federal Food, Drug, and Cosmetic Act to clarify the meaning of a new chemical entity. 1

AI Summary

This bill amends the Federal Food, Drug, and Cosmetic Act to clarify the meaning of a "new chemical entity." Specifically, it replaces references to "active ingredient" with "active moiety" (the molecule or ion responsible for the physiological or pharmacological action of a drug substance) in various sections of the Act related to drug approvals and exclusivities. This change aligns the language in the Act with the definition of "active moiety" used by the Food and Drug Administration in its regulations.

Committee Categories

Business and Industry, Health and Social Services

Sponsors (4)

Last Action

Referred to the Subcommittee on Health. (on 11/01/2019)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...